Second harmonic imaging of an intravenously administered echocardiographic contrast agent: Visualization of coronary arteries and measurement of coronary blood flow

Journal of the American College of Cardiology

Volumn 27, Issue 6, 1996, Pages 1519-1525

  Mulvagh, Sharon L ^a,b   Foley, David A ^a   Aeschbacher, Beat C ^a   Klarich, Kyle K ^a   Seward, James B ^a  

^a MAYO CLINIC   (United States)

^b Alliance Pharmaceutical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CONTRAST MEDIUM; PERFLUOROOCTYL BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B SCAN; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOG; DOPPLER ECHOCARDIOGRAPHY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030007528     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00619-2     Document Type: Article

References (43)

1. Feinstein SB, Cheirif J, Ten Gate FJ, et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 1990;16:316-24.
2. Schlief R, Schürmann R, Niendorf HP. Blood-pool enhancement with SHU 508 A: results of phase II clinical trials. Invest Radiol 1991;26:S188-9.
3. Tei C, Sakamaki T, Shah PM, et al. Myocardial contrast echocardiography: a reproducible technique of myocardial opacification for identifying regional perfusion deficits. Circulation 1983;67:585-93.
4. Armstrong WF, Mueller TM, Kinney EL, Tickner EG, Dillon JC, Feigenbaum H. Assessment of myocardial perfusion abnormalities with contrast-enhanced two-dimensional echocardiography. Circulation 1982;66:166-73.
5. Reisner SA, Ong LS, Lichtenberg GS, et al. Myocardial perfusion imaging by contrast echocardiography with use of intracoronary sonicated albumin in humans. J Am Coll Cardiol 1989;14:660-5.
6. Kaul S, Pandian NG, Okada RD, Pohost GM, Weyman AE. Contrast echocardiography in acute myocardial ischemia: I. in vivo determination of total left ventricular "area at risk." J Am Coll Cardiol 1984;4:1272-82.
7. Kemper AJ, O'Boyle JE, Sharma S, et al. Hydrogen peroxide contrast-enhanced two-dimensional echocardiography: real-time in vivo delineation of regional myocardial perfusion. Circulation 1983;68:603-11.
8. Goldman ME, Mindich BP. Intraoperative cardioplegic contrast echocardiography for assessing myocardial perfusion during open heart surgery. J Am Coll Cardiol 1984;4:1029-34.
9. Villanueva FS, Spotnitz WD, Jayaweera AR, Dent J, Gimple LW, Kaul S. On-line intraoperative quantitation of regional myocardial perfusion during coronary artery bypass graft operations with myocardial contrast two-dimensional echocardiography. J Thorac Cardiovasc Surg 1992;104:1524-31.
10. Ten Cate FJ, Drury JK, Meerbaum S, Noordsy J, Feinstein S, Shah PM. Myocardial contrast two-dimensional echocardiography: experimental examination at different coronary flow levels. J Am Coll Cardiol 1984;3:1219-26.
11. Cheirif J, Zoghbi WA, Raizner AE, et al. Assessment of myocardial perfusion in humans by contrast echocardiography. I. Evaluation of regional coronary flow reserve by peak contrast intensity. J Am Coll Cardiol 1984;11:735-43.
12. Keller MK, Glasheen W, Smucker ML, Burwell LR, Watson DD, Kaul S. Myocardial contrast echocardiography in humans. II. Assessment of coronary blood flow reserve. J Am Coll Cardiol 1988;12:925-34.
13. Ito H, Tomooka T, Sakai N., et al. Lack of myocardial perfusion immediately after successful thromobolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
14. Lang RM, Feinstein SB, Feldman T, Neumann A, Chua KG, Borow KM. Contrast echocardiography for evaluation of myocardial perfusion: effects of coronary angioplasty. J Am Coll Cardiol 1986;8:232-5.
15. Forsberg F, Liu J, Merton DA, Rawool NM, Goldberg BB. In vivo evaluation of a new ultrasound contrast agent. IEEE Trans Biomed Eng 1994;3:1555-8.
16. Camarano GP, Ismail S, Goodman NC, Kaul S. Assessment of risk area during coronary occlusion and infarct size after reperfusion can be determined with myocardial contrast echocardiography using intravenous injections of FS-069, a new contrast agent [abstract]. Circulation 1994;90 Suppl 1:I-68.
17. Grauer S, Pantely GA, Xu J, et al. Aerosomes® MRX 115: echocardiographic and hemodynamic characteristics of new echo contrast agent that produces myocardial opacification after intravenous injection in pigs [abstract]. Circulation 1994;90 Suppl I:I-556.
18. Porter TR, Xie F. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases. J Am Coll Cardiol 1995;25:509-15.
19. Mulvagh SL, Foley DA, Aeschbacher BC, Klarich KK, Seward JB. A new intravenous perfluorochemical echocardiographic contrast agent, Imagent® US: imaging characteristics and hemodynamic profile [abstract]. J Am Soc Echocardiogr 1995;8:345.
20. Dittrich HC, Bales GL, Kuvelas T, Hunt RM, McFerran BA, Greener Y. Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent. J Am Soc Echocardiogr 1995;8:465-74.
21. Porter TR, Feng X, Kricsfeld A, Kilzer K. Noninvasive identification of acute myocardial ischemia and reperfusion with contrast ultrasound using intravenous perfluoropropane-exposed sonicated dextrose albumin. J Am Coll Cardiol 1995;26:33-40.
22. Schrope B, Newhouse VL, Uhlendorf V. Simulated capillary blood flow measurement using a nonlinear ultrasonic contrast agent. Ultrason Imaging 1992;14:134-58.
23. Schrope BA, Newhouse VL. Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol 1993;19:567-79.
24. Miller DL. Ultrasonic detection of resonant cavitation bubbles in a flow tube by their second-harmonic emissions. Ultrasonics 1981;19:217-24.
25. de Jong N, Ten Cate FJ, Lancée CT, Roelandt JR, Bom N. Principles and recent developments in ultrasound contrast agents. Ultrasonics 1991;29:324-30.
26. Tucker DG, Welsby VG. Ultrasonic monitoring of decompression [letter]. Lancet 1968;1:1253.
27. Eatock BC, Nishi RY. Numerical studies of the spectrum of low-intensity ultrasound scattered by bubbles. J Acoust Soc Am 1985;77:1692-701.
28. Burns PN, Powers JE, Simpson DH et al. Harmonic power mode Doppler using microbubble contrast agents: an improved method for small vessel flow imaging. IEEE Trans Biomed Eng 1994;3:1547-50.
29. Chang PH, Shung KK. Second harmonic imaging and harmonic Doppler measurements with Albunex. IEEE Trans Biomed Eng 1994;3:1551-4.
30. de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part one: simulations. Ultrasonics 1994;32:447-53.
31. de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part two: measurements. Ultrasonics 1994;32:455-9.
32. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
33. Mahmud E, Cotter B, Kimura B, et al. Second harmonic imaging enhances contrast echocardiography in patients with cardiac disease: demonstration of feasibility [abstract]. J Am Coll Cardiol 1995;25:39A.
34. Clarke GD, Eckels R, Chaney C, et al. Measurement of absolute epicardial coronary artery flow and flow reserve with breath-hold cine phase-contrast magnetic resonance imaging. Circulation 1995;91:2627-34.
35. Edelman RR, Manning WJ, Burstein D, Paulin S. Coronary arteries: breath-hold MR angiography. Radiology 1991;181:641-3.
36. Weiss RM, Grover-McKay M. Assessment of coronary artery patency with cine computed tomography in a dog model of occlusion-reperfusion. Invest Radiol 1994;29:168-71.
37. Iliceto S, Marangelli V, Memmola C, Rizzon P. Transesophageal Doppler echocardiography evaluation of coronary blood flow velocity in baseline conditions and during dipyridamole-induced coronary vasodilation. Circulation 1991;83:61-9.
38. Redberg RF, Sobol Y, Chou TM, et al. Adenosine-induced coronary vasodilation during transesophageal Doppler echocardiography. Rapid and safe measurement of coronary flow reserve ratio can predict significant left anterior descending coronary stenosis. Circulation 1995;92:190-6.
39. Ten Cate FJ, Silverman PR, Sassen LM, Verdouw PD. Can myocardial contrast echo determine coronary flow reserve? Cardiovasc Res 1992;26: 32-9.
40. Porter TR, D'Sa A, Turner C, et al. Myocardial contrast echocardiography for the assessment of coronary blood flow reserve: validation in humans. J Am Coll Cardiol 1993;21:349-55.
41. Kaul S, Jayaweera AR. Myocardial contrast echocardiography has the potential for the assessment of coronary microvascular reserve. J Am Coll Cardiol 1993;21:356-8.
42. Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-911.
43. Blair E. Anatomy of the ventricular coronary arteries in the dog. Circ Res 1961;9:333-41.